Evidence map›Paper›PMID 33156858›Full record

ArticlePloS one2020

Analysis of RNA yield in extracellular vesicles isolated by membrane affinity column and differential ultracentrifugation.

Gilberto Gutiérrez García, Gabriela Galicia García, Jessica Zalapa Soto, Andrea Izquierdo Medina, Mariana Rotzinger-Rodríguez, Gustavo Antonio Casas Aguilar, Cynthia Paola López Pacheco, Álvaro Aguayo, Maria Montserrat Aguilar-Hernandez

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Blood Pressure and Late Pregnancy Circulating miRNAs in the MADRES Study.Journal of the American Heart Association · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. [Research progress and clinical application value of exosomal circRNAs in hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gilberto Gutiérrez GarcíaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico, Mexico.
Gabriela Galicia GarcíaFacultad de Medicina, PECEM, UNAM, Mexico, Mexico.
Jessica Zalapa SotoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico, Mexico.
Andrea Izquierdo MedinaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico, Mexico.
Mariana Rotzinger-RodríguezFacultad de Medicina, Universidad Anahuac, Mexico, Mexico.
Gustavo Antonio Casas AguilarFacultad de Medicina, PECEM, UNAM, Mexico, Mexico.
Cynthia Paola López PachecoLaboratorio Nacional de Citometria de Flujo, Investigaciones Biomédicas UNAM, Mexico, Mexico.
Álvaro AguayoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico, Mexico.
Maria Montserrat Aguilar-HernandezInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico, Mexico.ORCID 0000-0001-8449-4359

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular vesicles (EV) have attracted much attention as potential biomarkers due to their protein, RNA and other nucleic acid content. The most common method used for EV isolation is differential ultracentrifugation (DU), however given the DU technical difficulties, other more practical methods have surged, such as membrane-affinity column commercial kits. Here, we assessed one commercial kit in terms of EV recovery and EV-derived RNA yield and compared it with a DU protocol. Our data shows that the commercial kit preparation results in a lower count of EV-like structures and a reduced expression of EV markers when compared to DU samples. Thus, apparently suggesting that the commercial kit had a lower EV yield. However, these findings did not reflect on RNA yield, which was greater with the commercial kit, even after an enzymatic treatment with proteinase K and RNAse A. We conclude that the kit has a higher EV-derived RNA yield in comparison to our DU protocol, suggesting that it may be the method of choice for RNA sequencing purposes.

Indexed as

BiomarkersCell Line, TumorExtracellular VesiclesHumansMembranesRNAUltracentrifugationBiomarkersRNA

Identifiers

PMID33156858
PMCPMC7647092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.